---
id: antimicrobials_tmp-smx-mechanism-spectrum_020
category: antimicrobials
tags: [antimicrobials, tmp-smx, mechanism, spectrum, MRSA, nocardia, stenotrophomonas]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## TMP-SMX: Mechanism and Spectrum

**Q:** What is the mechanism of TMP-SMX and what are its key pathogens in its spectrum?

**A:**
**Mechanism:** Sequential blockade of bacterial folate synthesis
- **Sulfamethoxazole:** Inhibits dihydropteroate synthetase (blocks dihydrofolate formation)
- **Trimethoprim:** Inhibits dihydrofolate reductase (DHFR, blocks tetrahydrofolate formation)
- Synergistic combination â†’ bactericidal

**Spectrum highlights:**
- **MRSA** (community-acquired strains, first-line for skin/soft tissue)
- **Nocardia** (drug of choice)
- **Stenotrophomonas maltophilia** (intrinsically resistant to most antibiotics)
- **Pneumocystis jirovecii** (first-line for treatment and prophylaxis)
- **Listeria monocytogenes** (alternative to ampicillin)
- Gram-negatives: Most *Enterobacterales* (E. coli, Klebsiella), but **NOT Pseudomonas**

**Mnemonic: "SMNS-LP"**
- **S**tenotrophomonas
- **M**RSA
- **N**ocardia
- **S**tenotrophomonas (emphasis on uniqueness)
- **L**isteria
- **P**neumocystis

**Media:** None

**Sources:** [StatPearls 2024], [IDSA Guidelines], [PubMed: Infection 2024 - Nocardia dosing], [NIH HIV/AIDS Guidelines 2024]
